Motor neuron disease is clinically characterized by progressive muscle
wasting leading to total muscle paralysis. A long history of patholog
ical study of patients has firmly established that the primary lesion
site is in spinal and cortical motor neurons. In addition to the wides
pread loss of these neurons, neuronal abnormalities including massive
accumulation of neurofilaments in cell bodies and proximal axons have
been also widely observed, particularly in the early stages of the dis
ease. To test whether high accumulation of neurofilaments directly con
tributes to the pathogenic process, transgenic mice that produce high
levels of neurofilaments in motor neurons have been generated. These t
ransgenic mice show most of the hallmarks observed in motor neuron dis
ease, including swollen perikarya with eccentrically localized nuclei,
proximal axonal swellings, axonal degeneration and severe skeletal mu
scle atrophy. These data indicate that extensive accumulation of neuro
filaments in motor neurons can trigger a neurodegenerative process and
may be a key intermediate in the pathway of pathogenesis leading to n
euronal loss.